Agonist
Substance that activates a receptor
An agonist is a substance that binds to a receptor and turns it on. The binding produces the response that the receptor normally creates when its natural signal arrives. Many research peptides are studied because they act as agonists at specific receptors.
Used in 19 research peptides
- MetabolicTirzepatideWeight & Glucose Manager.
- MetabolicRetatrutideThe 'Godzilla' of weight loss; a triple-hormone agonist for unprecedented fat loss and metabolic health.
- CosmeticPT-141 (Bremelanotide)Melanocortin agonist FDA-approved (Vyleesi) for HSDD; libido enhancement.
- MetabolicCagrilintideAmylin analog co-developed with semaglutide as 'CagriSema' for next-gen weight loss.
- PerformanceAnamorelinOral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz.
- PerformanceCapromorelinOral non-peptide ghrelin-receptor agonist; FDA-approved as a veterinary appetite stimulant.
- MetabolicLiraglutideDaily GLP-1 analog; FDA-approved for diabetes (Victoza) and obesity (Saxenda®).
- MetabolicDulaglutideWeekly GLP-1 receptor agonist fused to an IgG4 Fc fragment; sold as Trulicity by Eli Lilly.
- MetabolicLixisenatideShort-acting prandial GLP-1 agonist; sold as Adlyxin/Lyxumia by Sanofi.
- MetabolicSurvodutideInvestigational GLP-1 / glucagon dual agonist from Boehringer Ingelheim and Zealand Pharma.
- MetabolicMazdutideGLP-1 / glucagon dual agonist (Innovent / Eli Lilly) submitted in China for obesity 2024.
- MetabolicOrforglipronFirst oral non-peptide GLP-1 receptor agonist (Eli Lilly); Phase 3 obesity program.
- RecoveryLarazotide AcetateTight-junction regulator developed for celiac disease; reduces intestinal permeability.
- SleepOrexin-A (Hypocretin-1)Hypothalamic neuropeptide regulating wakefulness; intranasal investigation for narcolepsy.
- MetabolicExenatideFirst-in-class GLP-1 mimetic derived from Gila monster venom; sold as Byetta/Bydureon.
- MetabolicAlbiglutideWeekly GLP-1 agonist fused to albumin; discontinued GSK product (Tanzeum/Eperzan).
- MetabolicRetatrutide + Cagrilintide StackInvestigational community stack pairing a triple incretin agonist with a long-acting amylin analog.
- MetabolicCagriSema (Cagrilintide + Semaglutide)Investigational once-weekly fixed combination of the amylin analog cagrilintide and the GLP-1 agonist semaglutide, studied in the Phase 3 REDEFINE program for weight management.
- PerformanceSLU-PP-332Investigational small-molecule ERR (estrogen-related receptor) agonist studied preclinically as an exercise mimetic. Mouse data only; no human studies. Educational use only.
See also
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.